Correlation Between Tumor-infiltrating Lymphocytes and Response to Systemic Therapy in Breast Cancer
NCT07404462
·
clinicaltrials.gov ↗
COMPLETED
Status
171
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Early Breast Cancer
Interventions
OTHER:
Standard-of-Care Neoadjuvant Chemotherapy
Sponsor
Institute of Oncology Ljubljana